Drug · DIN 02522802
SLYND
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 20, 2022; first marketed April 20, 2022.
- Drug Identification Number (DIN)
- 02522802
- Company (DIN owner)
- Duchesnay Inc.Blainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Drospirenone G03AC10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DROSPIRENONE | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 30, 2021: NOC 27131New Drug Submission (NDS)